Literature DB >> 15699131

Progressive differentiation and commitment of CD8+ T cells to a poorly cytolytic CD8low phenotype in the presence of IL-4.

Norbert Kienzle1, Stuart Olver, Kathy Buttigieg, Penny Groves, Michelle L Janas, Adriana Baz, Anne Kelso.   

Abstract

Exposure to IL-4 during activation of naive murine CD8+ T cells leads to generation of IL-4-producing effector cells with reduced surface CD8, low perforin, granzyme B and granzyme C mRNA, and poor cytolytic function. We show in this study that maximal development of these cells depended on exposure to IL-4 for the first 5 days of activation. Although IL-4 was not required at later times, CD8 T cell clones continued to lose surface CD8 expression with prolonged culture, suggesting commitment to the CD8low phenotype. This state was reversible in early differentiation. When single CD8low cells from 4-day cultures were cultured without IL-4, 65% gave rise to clones that partly or wholly comprised CD8high cells; the proportion of reverted clones was reduced or increased when the cells were cloned in the presence of IL-4 or anti-IL-4 Ab, respectively. CD8 expression positively correlated with perforin and granzyme A, B, and C mRNA, and negatively correlated with IL-4 mRNA levels among these clones. By contrast, most CD8low cells isolated at later time points maintained their phenotype, produced IL-4, and exhibited poor cytolytic function after many weeks in the absence of exogenous IL-4. We conclude that IL-4-dependent down-regulation of CD8 is associated with progressive differentiation and commitment to yield IL-4-producing cells with little cytolytic activity. These data suggest that the CD4-CD8- cells identified in some disease states may be the product of a previously unrecognized pathway of effector differentiation from conventional CD8+ T cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15699131     DOI: 10.4049/jimmunol.174.4.2021

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

Review 1.  IL-4: an important cytokine in determining the fate of T cells.

Authors:  J L Silva-Filho; C Caruso-Neves; A A S Pinheiro
Journal:  Biophys Rev       Date:  2014-01-09

Review 2.  Alternative activation of tumor-associated macrophages by IL-4: priming for protumoral functions.

Authors:  Hao-Wei Wang; Johanna A Joyce
Journal:  Cell Cycle       Date:  2010-12-15       Impact factor: 4.534

Review 3.  Targeting IL4/IL4R for the treatment of epithelial cancer metastasis.

Authors:  Katherine Venmar Bankaitis; Barbara Fingleton
Journal:  Clin Exp Metastasis       Date:  2015-09-18       Impact factor: 5.150

Review 4.  Human CD8+ T-regulatory cells with low-avidity T-cell receptor specific for minor histocompatibility antigens.

Authors:  William J Burlingham; Els Goulmy
Journal:  Hum Immunol       Date:  2008-09-21       Impact factor: 2.850

5.  Interferon-gamma and interleukin-4 reciprocally regulate CD8 expression in CD8+ T cells.

Authors:  Simon H Apte; Adriana Baz; Penny Groves; Anne Kelso; Norbert Kienzle
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-06       Impact factor: 11.205

6.  Interleukin-4-induced loss of CD8 expression and cytolytic function in effector CD8 T cells persists long term in vivo.

Authors:  Stuart Olver; Simon H Apte; Adriana Baz; Anne Kelso; Norbert Kienzle
Journal:  Immunology       Date:  2013-06       Impact factor: 7.397

7.  Dose-dependent modulation of CD8 and functional avidity as a result of peptide encounter.

Authors:  Charles J Kroger; Martha A Alexander-Miller
Journal:  Immunology       Date:  2007-05-02       Impact factor: 7.397

8.  Hydrolysis of tumor cell lipids after CTL-mediated death.

Authors:  Bryce Alves; Jeff Leong; David L Tamang; Viki Elliott; Mark Lowe; Dorothy Hudig
Journal:  Int Immunol       Date:  2009-03-26       Impact factor: 4.823

9.  CD8+ T cell activation and differentiation in allergic asthma and the impact of cytomegalovirus serological status.

Authors:  K Bratke; L Krieghoff; M Kuepper; W Luttmann; J C Virchow
Journal:  Clin Exp Immunol       Date:  2007-05-18       Impact factor: 4.330

10.  Genetic manipulation of tumor-specific cytotoxic T lymphocytes to restore responsiveness to IL-7.

Authors:  Juan F Vera; Valentina Hoyos; Barbara Savoldo; Concetta Quintarelli; Greta M P Giordano Attianese; Ann M Leen; Hao Liu; Aaron E Foster; Helen E Heslop; Cliona M Rooney; Malcolm K Brenner; Gianpietro Dotti
Journal:  Mol Ther       Date:  2009-03-03       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.